| Autor: |
Zurlo IV; Oncologia Medica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, Largo Francesco Vito n 1, 00168 Rome, Italy.; Oncologia Medica, Università Cattolica del Sacro Cuore, 00168 Rome, Italy., Calegari MA; Oncologia Medica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, Largo Francesco Vito n 1, 00168 Rome, Italy., Congedo MT; Unità di Chirurgia Toracica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, 00168 Rome, Italy., Basso M; Oncologia Medica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, Largo Francesco Vito n 1, 00168 Rome, Italy., Vita ML; Unità di Chirurgia Toracica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, 00168 Rome, Italy., Petracca Ciavarella L; Unità di Chirurgia Toracica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, 00168 Rome, Italy., Vivolo R; Oncologia Medica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, Largo Francesco Vito n 1, 00168 Rome, Italy., Anghelone A; Oncologia Medica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, Largo Francesco Vito n 1, 00168 Rome, Italy., Pozzo C; Oncologia Medica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, Largo Francesco Vito n 1, 00168 Rome, Italy., Salvatore L; Oncologia Medica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, Largo Francesco Vito n 1, 00168 Rome, Italy.; Oncologia Medica, Università Cattolica del Sacro Cuore, 00168 Rome, Italy., Meacci E; Unità di Chirurgia Toracica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, 00168 Rome, Italy.; Unità di Chirurgia Toracica, Università Cattolica del Sacro Cuore-IRCCS, 00168 Rome, Italy., Margaritora S; Unità di Chirurgia Toracica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, 00168 Rome, Italy.; Unità di Chirurgia Toracica, Università Cattolica del Sacro Cuore-IRCCS, 00168 Rome, Italy., Tortora G; Oncologia Medica, Fondazione Policlinico Universitario 'A Gemelli'-IRCCS, Largo Francesco Vito n 1, 00168 Rome, Italy.; Oncologia Medica, Università Cattolica del Sacro Cuore, 00168 Rome, Italy. |
| Abstrakt: |
Background : Unlike liver metastases, the role of surgery in colorectal cancer lung-limited metastases (CCLLM) is not yet established, and data are still poor. We performed a retrospective analysis to evaluate the impact of surgery on the management of CCLLM. Material and Method : We retrospectively analyzed patients who received surgery for CCLLM at our Institution from January 2010 to June 2019. The aim of the study was to evaluate the impact of clinical and pathological features on the survival (OS and DFS) of patients treated with surgery for CCLLM. Results : One hundred and fifty patients were included in the analysis. Seventy-six patients received preoperative chemotherapy (pCT) and 56 an adjuvant treatment (aCT), while 18 underwent up-front surgery without CT. In the whole population, median OS (mOS) and median DFS (mDFS) were 54.1 months (95%CI 44.0-82.1) and 24.0 months (95%CI 20.0-31.2), respectively. In multivariate analysis, number of metastases was the only factor correlated to DFS ( p = 0.0006) and OS ( p = 0.0018). Conclusion : Our study, although retrospective and of small size, shows that tumor burden (number of metastases) is the main prognostic factor in patients undergoing lung surgery for CCLLM. Moreover, our results suggest that surgery for lung metastases might prolong survival. These data strengthen the role of multidisciplinary management to allow patients with CCLLM to pursue local treatment whenever possible, even regardless of previous liver surgery or RAS mutated status. |
